AMY ROSSITER: Open Payments
NPI 1255658951 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,268 in 158 payments from 18 companies in 2025. Trend: 2023 $556 · 2024 $3,219 · 2025 $4,268
Food & beverage: $4,135Education: $133
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $763 |
| ABBVIE INC. | 37 | $683 |
| Regeneron Healthcare Solutions, Inc. | 17 | $477 |
| Incyte Corporation | 16 | $425 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $423 |
| GENZYME CORPORATION | 12 | $348 |
| Lilly USA, LLC | 12 | $295 |
| UCB, Inc. | 10 | $248 |
| Arcutis Biotherapeutics, Inc. | 6 | $211 |
| LEO Pharma Inc. | 4 | $76 |
Products named: DUPIXENT, TREMFYA, OPZELURA, RINVOQ, SKYRIZI, Bimzelx, Zoryve, Winlevi.
Industry payments across NY — which companies pay providers there.
